Evaluating the Added Predictive Ability of a New Marker¶
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008). Evaluating the Added Predictive Ability of a New Marker: From Area Under the ROC Curve to Reclassification and Beyond. Statistics in Medicine, 27(2), 157-172.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Feature Engineering
- The clinical biomarker pipeline (candidate, validate, control for confounding, characterize the noise floor, set a decision threshold) transfers to public-policy indicator design, and indicators built without an analogous pipeline routinely fail.
This sourceExemplifies the biomarker validation pipeline (candidate, validate, characterize added value) whose discipline transfers to indicator design, supporting the clinical-to-policy pipeline transfer.
- The clinical biomarker pipeline (candidate, validate, control for confounding, characterize the noise floor, set a decision threshold) transfers to public-policy indicator design, and indicators built without an analogous pipeline routinely fail.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:f4db5f014b9d · see in the full table